Compare Enzyme (MLN) vs Slash Vision Labs (SVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Slash Vision Labs — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Slash Vision Labs trades at Rp58.98 (market cap --, Rp1,93M 24h volume). The key difference: Enzyme's circulating supply is 3,3M MLN versus -- for Slash Vision Labs, and Enzyme is more actively traded (Rp104,56M versus Rp1,93M). Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Slash Vision Labs for 10 Days on average.
| MLN | SVL | |
|---|---|---|
Market Cap | Rp134,13M | -- |
Volume (24h) | Rp104,56M | Rp1,93M |
Circulating Supply | 3,3M MLN | -- |
Typical Hold Time | 29 Days | 10 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
SVL is currently trading at Rp 58.913, exhibiting a mixed technical picture with a bullish overall signal but bearish moving averages. Key resistance lies at Rp 65 (R1) with support at Rp 56 (S1). The token's max supply is capped at 10 million, and the average hold time is 10 days, indicating relatively short-term holding patterns. No major recent protocol updates or ecosystem news were identified.
The outlook is cautiously optimistic due to bullish oscillators, but risks include high volatility and proximity to resistance. Key opportunities lie in a breakout above Rp 65, while major risks are the bearish moving average trend and low liquidity. Investors should monitor volume and on-chain activity closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Slash Vision Labs
Slash Vision Labs is a cryptocurrency payments platform designed to simplify the use of digital assets in everyday transactions. As the creator of Japan's first compliant crypto-backed credit card, Slash Vision Labs bridges the gap between traditional finance and digital currencies. The Slash Card, along with the SVL token, serves as an entry point for new users in Japan who are exploring the world of cryptocurrency. By offering secure, self-custodial payment solutions, Slash Vision Labs makes it easier to integrate cryptocurrency into daily life.
Read more on SVL →
